RE:Some ideas for CXRhey select: CXR management has already said and reiterated 90% of these things on multiple occassions, and will continue to do so, I am certain, as they feel is appropriate in the circumstances. It is pretty obvious to all of us who have been following the CXR story for more than a month that there is no affiliation or comparison to the VRX story to warrant any negative price movement in step with VRX based on the criticisms of VRX's methods of operation and pricing, etc. I suspect whoever the sellers were know full well that selling CXR based on VRX story is a very weak reasoning. Obviously, the VRX selloff was much more aggressive than CXR and other healthcare names since there is no news related to CXR that warrants a decrease in sp. It may have just been some profit taking after moving from 34 to 40 dollars from Feb 11. Cheers and GL.